Skip to main content Skip to search Skip to main navigation
Go to homepage

Seraseq® Lymphoma DNA Mutation Mix

Product information "Seraseq® Lymphoma DNA Mutation Mix "

To help clinical labs performing NGS-based lymphoid testing better develop, characterize, validate and routinely assess lymphoid diseases by NGS assays, LGC SeraCare has developed the Seraseq Lymphoma DNA Mutation Mix and Seraseq FFPE Lymphoma Reference Material, the first set of comprehensive lymphoid cancer NGS assay reference materials. These unique products include clinically important SNVs, INDELs and gene fusions important in lymphoma disease diagnosis and prognosis. Variants are present against a single well-characterized genomic background (GM24385) at clinically relevant allele frequencies, precisely quantitated by digital PCR assays.
Product type: Control & reference materials
Regulatory status: RUO
Content: 15 ng/µl
Quantity: 1 x 25 µl
Storage temperature: -20 °C
Shipping method: Dry ice
Country of distribution: Germany, Austria
Questions?
Get in touch with us. We look forward to helping you.
Seraseq® Lymphoma DNA Mutation Mix
€1,698.00*